Home
- About PMI
  - Welcome to PMI Science
  - Our Standards
  - Our Scientists
  - Our Initiatives
  - Interactive tour of the Cube
  - Our Network
- Smoke-free approach
  - What is harm reduction?
  - Absence of combustion
  - Nicotine
  - The role of smoke-free products
  - Tar
  - Tobacco Regulation
- Research
  - Our Scientific Approach
  - Our Findings
  - PMI Publications Library
  - Literature Reviews
  - Independent Studies
  - Expert Reports
  - Investigator initiated studies (IIS)
  - Latest PMI Science Booklet
  - Facts and figures on our smoke-free future
- Our Products
  - Tobacco Heating System
  - Oven Heating System
  - MESH Vaping System
  - Disposable Vaping System
  - Oral Nicotine Pouches
  - Nicotine salts product
- News & Events
  - Scientific Update Magazine
  - Open Science Events
  - News
  - Conferences Calendar
  - Media Library
- Contact Us

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2019

ISPOR (International Society for Pharmacoeconomics and Outcomes Research) is recognized globally as the leading educational and scientific organization for health economics and outcomes research (HEOR) and its use in healthcare decisions. ISPOR 2019 will feature three thought-provoking plenary sessions and presentations in the form of workshops, issue panels, forums, symposia, and podium and poster presentations on innovative research methods, health policy development using outcomes research, patient preferences, real-world data, and clinical-, economic-, and patient-reported outcomes. In addition, ISPOR offers a series of pre-meeting short (training) courses on trending HEOR topics. ISPOR short courses range from introductory to advanced, and are taught by leading experts in the field, with many incorporating group exercises and hands- on training opportunities. The ISPOR scope and sphere of influence includes the international HEOR community of global leaders, policy makers, regulators, researchers, academicians, payers, patients, and patient groups. This multistakeholder group is invested in using science and research to make better health care decisions. The diversity in work environments and international scope of attendance provide excellent networking opportunities and stimulating discussions and debate.

PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.